Insider Trading History of Anish Bhatnagar

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Anish Bhatnagar since 2015. This trader's CIK number is 1614821. At the time of last reporting, Anish Bhatnagar was the CHIEF EXECUTIVE OFFICER of Soleno Therapeutics Inc. (stock ticker symbol SLNO). Also see all insider trading activities at Soleno Therapeutics Inc.


Yearly summary of insider trading at Soleno Therapeutics Inc (SLNO) by Anish Bhatnagar

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SLNO 0 $0 720,186 $48,914,799 523,809 $8,329,610
2024 SLNO 0 $0 285,764 $13,238,062 0 $0
2023 SLNO 0 $0 174,629 $5,641,161 9,643 $28,128
2022 SLNO 60,000 $0 39,033 $14,559 0 $0
2016 SLNO 10,000 $9,600 0 $0 58,419 $70,102
2015 SLNO 10,000 $16,400 0 $0 0 $0


Insider trading of Soleno Therapeutics Inc (SLNO) by Anish Bhatnagar

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-27 SLNO Option Ex 523,809 15.90 8,329,610
2025-03-27 SLNO Sale 699,095 68.58 47,946,731
2025-01-02 SLNO Sale 10,937 45.64 499,197
2025-01-03 SLNO Sale 10,154 46.18 468,871
2024-10-01 SLNO Sale 21,633 49.79 1,077,150
2024-08-29 SLNO Sale 58,391 47.50 2,773,338
2024-08-28 SLNO Sale 56,613 47.61 2,695,344
2024-08-05 SLNO Sale 58,213 45.81 2,666,737
2024-08-06 SLNO Sale 69,131 44.93 3,105,779
2024-07-01 SLNO Sale 19,256 41.42 797,660
2024-01-25 SLNO Sale 2,527 48.30 122,054
2023-12-11 SLNO Sale 93,408 36.09 3,370,907
2023-10-20 SLNO Option Ex 9,643 2.92 28,128
2023-11-30 SLNO Sale 27,716 28.65 794,118
2023-11-29 SLNO Sale 27,827 27.85 774,870
2023-11-28 SLNO Sale 25,678 27.31 701,266
2022-03-31 SLNO Buy 60,000 .00 0
2022-01-21 SLNO Sale 39,033 .37 14,559
2016-08-19 CAPN Buy 10,000 .96 9,600
2016-04-08 CAPN Option Ex 58,419 1.20 70,102
2015-08-12 CAPN Buy 10,000 1.64 16,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anish Bhatnagar (CHIEF EXECUTIVE OFFICER of Soleno Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.